Farnesoid X Receptor Activation Protects Liver From Ischemia/Reperfusion Injury by Up-Regulating Small Heterodimer Partner in Kupffer Cells
- PMID: 32258949
- PMCID: PMC7109340
- DOI: 10.1002/hep4.1478
Farnesoid X Receptor Activation Protects Liver From Ischemia/Reperfusion Injury by Up-Regulating Small Heterodimer Partner in Kupffer Cells
Abstract
Farnesoid X receptor (FXR) is the nuclear receptor of bile acids and is involved in innate immune regulation. FXR agonists have been shown to protect multiple organs from inflammatory tissue injuries. Because liver expresses high levels of FXR, we explored the potential therapeutic benefits and underlying mechanisms of pharmacologic FXR activation in a murine model of partial liver warm ischemia. Pretreatment of mice with FXR agonist 3-(2,6-dichlorophenyl)-4-(3'-carboxy-2-chlorostilben-4-yl)oxymethyl-5-isopropylisoxazole (GW4064) attenuated liver ischemia/reperfusion injuries (IRIs) in wild-type but not FXR knockout mice. Posttreatment with GW4064 facilitated liver recovery from IRI. Mechanistically, Kupffer cells (KCs) expressed much higher levels of FXR than bone marrow-derived macrophages (BMMs). Pretreatment of KCs but not BMMs with GW4064 resulted in lower tumor necrosis factor α but higher interleukin-10 expressions following toll-like receptor stimulation. FXR-targeted gene small heterodimer partner (SHP) was critical for the regulation of KC response by GW4064. In vivo, the depletion of KCs but not cluster of differentiation (CD) 11b+ cells or knockdown of SHP diminished the immune regulatory effect of GW4064 in liver IRI. Thus, FXR activation protects liver from IRI by up-regulating SHP in KCs to inhibit the liver proinflammatory response.
© 2020 The Authors. Hepatology Communications published by Wiley Periodicals, Inc., on behalf of the American Association for the Study of Liver Diseases.
Figures







Similar articles
-
GW4064, an agonist of farnesoid X receptor, represses CYP3A4 expression in human hepatocytes by inducing small heterodimer partner expression.Drug Metab Dispos. 2015 May;43(5):743-8. doi: 10.1124/dmd.114.062836. Epub 2015 Feb 27. Drug Metab Dispos. 2015. PMID: 25725071 Free PMC article.
-
Glycogen synthase kinase 3β promotes liver innate immune activation by restraining AMP-activated protein kinase activation.J Hepatol. 2018 Jul;69(1):99-109. doi: 10.1016/j.jhep.2018.01.036. Epub 2018 Feb 13. J Hepatol. 2018. PMID: 29452207 Free PMC article.
-
Small heterodimer partner overexpression partially protects against liver tumor development in farnesoid X receptor knockout mice.Toxicol Appl Pharmacol. 2013 Oct 15;272(2):299-305. doi: 10.1016/j.taap.2013.06.016. Epub 2013 Jun 26. Toxicol Appl Pharmacol. 2013. PMID: 23811326 Free PMC article.
-
Farnesoid X receptor, the bile acid sensing nuclear receptor, in liver regeneration.Acta Pharm Sin B. 2015 Mar;5(2):93-8. doi: 10.1016/j.apsb.2015.01.005. Epub 2015 Feb 20. Acta Pharm Sin B. 2015. PMID: 26579433 Free PMC article. Review.
-
Bile acid nuclear receptor FXR and digestive system diseases.Acta Pharm Sin B. 2015 Mar;5(2):135-44. doi: 10.1016/j.apsb.2015.01.004. Epub 2015 Feb 25. Acta Pharm Sin B. 2015. PMID: 26579439 Free PMC article. Review.
Cited by
-
Sex differences feed into nuclear receptor signaling along the digestive tract.Biochim Biophys Acta Mol Basis Dis. 2021 Nov 1;1867(11):166211. doi: 10.1016/j.bbadis.2021.166211. Epub 2021 Jul 14. Biochim Biophys Acta Mol Basis Dis. 2021. PMID: 34273530 Free PMC article. Review.
-
Phenotyping the Chemical Communications of the Intestinal Microbiota and the Host: Secondary Bile Acids as Postbiotics.Cells. 2025 Apr 15;14(8):595. doi: 10.3390/cells14080595. Cells. 2025. PMID: 40277921 Free PMC article. Review.
-
Farnesoid X receptor: From Structure to Function and Its Pharmacology in Liver Fibrosis.Aging Dis. 2024 Aug 1;15(4):1508-1536. doi: 10.14336/AD.2023.0830. Aging Dis. 2024. PMID: 37815898 Free PMC article. Review.
-
The long and the small collide: LncRNAs and small heterodimer partner (SHP) in liver disease.Mol Cell Endocrinol. 2021 May 15;528:111262. doi: 10.1016/j.mce.2021.111262. Epub 2021 Mar 26. Mol Cell Endocrinol. 2021. PMID: 33781837 Free PMC article. Review.
-
Hepatoprotective Effects of Glycyrrhetinic Acid on Lithocholic Acid-Induced Cholestatic Liver Injury Through Choleretic and Anti-Inflammatory Mechanisms.Front Pharmacol. 2022 May 31;13:881231. doi: 10.3389/fphar.2022.881231. eCollection 2022. Front Pharmacol. 2022. PMID: 35712714 Free PMC article.
References
-
- Ohkohchi N. Mechanisms of preservation and ischemic/reperfusion injury in liver transplantation. Transplant Proc 2002;34:2670‐2673. - PubMed
-
- Tsai YF, Liu FC, Sung WC, Lin CC, Chung PC, Lee WC, et al. Ischemic reperfusion injury‐induced oxidative stress and pro‐inflammatory mediators in liver transplantation recipients. Transplant Proc 2014;46:1082‐1086. - PubMed
-
- Kaczorowski DJ, Tsung A, Billiar TR. Innate immune mechanisms in ischemia/reperfusion. Front Biosci (Elite Ed) 2009;1:91‐98. - PubMed